The Psychedelic Science Funders Collaborative is a community of philanthropists dedicated to enabling access to psychedelic healing for all who can benefit.

There is abundant and growing evidence that psychedelic substances hold enormous promise for human wellbeing, particularly in addressing the current mental health crisis. Clinical trials have demonstrated psychedelics’ potential in treating the most challenging conditions, providing hope for those who have not found relief through conventional therapies. Moreover, psychedelics could play a role in tackling broader societal challenges by fostering interconnectedness and empathy, potentially reducing conflict and enhancing cooperation. These substances have been used for thousands of years in various cultural and spiritual practices, indicating their longstanding value in personal and communal healing. 

However, the contemporary science behind psychedelics is still evolving, with many unknowns about their true potential for different needs, their optimal delivery, and their inherent risks. The resurgence of interest in psychedelics reflects a reawakening to their potential, but it is crucial to approach this with caution and rigorous scientific inquiry. This exploration represents a merging of ancient wisdom with modern science, offering the potential to reshape how we approach both individual and collective well-being, while acknowledging that much remains to be learned.

In this context, the Psychedelic Science Funders Collaborative (PSFC), a 501(c)(3) nonprofit, was established in 2017 as a funding collaborative dedicated to supporting leaders and organizations advancing access to psychedelic healing. PSFC has played a crucial role in advancing the field and laying groundwork for the large systems changes needed to fully realize the potential of psychedelic healing.


Our Vision

PSFC is a community of philanthropists committed to building a world with access to psychedelic healing for all who can benefit.


Our Mission

Together as philanthropists, we seek to connect, to learn, and to advance the psychedelic field by leveraging targeted funding, informed by world class expertise, and powered by our collaborative network.